TRANSCRIPTIONAL REGULATION OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR GENE IN HUMAN ENDOTHELIAL-CELLS - IDENTIFICATION OF NUCLEAR FACTORS THAT RECOGNIZE FUNCTIONAL ELEMENTS IN THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR GENE PROMOTER
M. Costa et al., TRANSCRIPTIONAL REGULATION OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR GENE IN HUMAN ENDOTHELIAL-CELLS - IDENTIFICATION OF NUCLEAR FACTORS THAT RECOGNIZE FUNCTIONAL ELEMENTS IN THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR GENE PROMOTER, European journal of biochemistry, 258(1), 1998, pp. 123-131
The gene encoding human tissue-type plasminogen activator (t-PA) is re
gulated in a cell-type-specific manner. Previous studies in non-endoth
elial cells have indicated that basal and phorbol ester mediated induc
tion is controlled by a cAMP response element (CRE) referred to as the
tPACRE, and an activating protein 2 (AP-2)-like site. The classificat
ion of the AP-2-like site was assigned on the basis of its sequence ho
mology, but has been shown in some cell systems to be recognised by pr
omoter-specific transcription factor-1 (Sp-1). Here, we have investiga
ted the transcriptional regulation of the t-PA gene in endothelial cel
ls and addressed the functional roles of the tPACRE and the Sp-1/AP-2-
like sites. 5'-RACE experiments indicate that the t-PA gene uses two t
ranscription initiation sites in these cells with the downstream site
being preferred. Functional analyses of the t-PA promoter using report
er-gene constructs transfected into C11STH endothelial cells demonstra
te that the first 410 bp of the t-PA promoter confers an increase in r
eporter-gene activity on treatment with 4 beta-phorbol 12-myristate 13
-acetate (PMA). Mutagenesis of either the tPACRE or the Sp-1/AP-2 site
weakens both basal and inducible expression, while disruption of both
sites renders the promoter completely unresponsive. Using supershift
assays, we identify the predominant tPACRE-binding proteins in nuclear
extracts prepared from both C11STH cells and primary umbilical vein e
ndothelial cells (HUVECs) as activating transcription factor 2, CREB (
cAMP-responsive-element-binding protein), CREM (cAMP response element
modulator) and c-jun. Treatment of cells with PMA results in a selecti
ve recruitment of jun-D to the tPACRE, while Sp-l was identified as th
e major transcription factor that recognises the AP-2-like site. Based
on this data and previous reports, we have reassigned this as a Sp-l-
binding site. Finally, the identification of specific endothelial-deri
ved t-PACRE-binding proteins suggests an integral role for these facto
rs in the regulation of t-PA gene expression in human endothelial cell
s.